{
  "generation_timestamp": "2025-11-06T12:55:08.829119",
  "query": "Cognitive Wars: The AI Industrialization of Influence",
  "days_back": 7,
  "report_stats": {
    "character_count": 31772,
    "word_count": 3846,
    "jsonld_size": 3780
  },
  "confidence_score": 0.715,
  "sources_count": 11,
  "system_info": {
    "agent_type": "Enhanced STI Agent",
    "version": "1.0.0",
    "model": "gpt-5-mini-2025-08-07",
    "date_filtering": "Strict 7-day window enforced"
  },
  "agent_stats": {
    "date_filter_stats": {
      "total_processed": 26,
      "within_window": 8,
      "outside_window": 18,
      "parse_failed": 0,
      "success_rate": 0.3076923076923077,
      "parse_success_rate": 1.0
    },
    "sources_data": [
      {
        "id": 1,
        "title": "An Investigation into the Performances of the State-of-the-art Machine Learning Approaches for Various Cyber-attack Detection: A Survey",
        "url": "http://arxiv.org/abs/2402.17045v2",
        "publisher": "Arxiv.Org",
        "date": "2024-02-26",
        "credibility": 0.5,
        "content_sha": null
      },
      {
        "id": 2,
        "title": "OA1‐AM23‐SN‐05 | Canadian Pediatric Massive Hemorrhage Protocols: A Survey of National Practice and State‐of‐the‐Art Review",
        "url": "https://doi.org/10.1111/trf.52_17554",
        "publisher": "Doi.Org",
        "date": "2023-10-01",
        "credibility": 0.5,
        "content_sha": null
      },
      {
        "id": 3,
        "title": "Conditions for detectability in distributed consensus-based observer networks",
        "url": "http://arxiv.org/abs/1303.6397v1",
        "publisher": "Arxiv.Org",
        "date": "2013-03-26",
        "credibility": 0.5,
        "content_sha": null
      }
    ],
    "validated_sources_count": 11,
    "intent": "theory",
    "horizon": "Foundational",
    "hybrid_thesis_anchored": false,
    "thesis_io": {},
    "confidence_breakdown": {
      "source_diversity": 0.5333333333333333,
      "anchor_coverage": 1.0,
      "method_transparency": 0.7,
      "replication_readiness": 0.65
    },
    "advanced_tasks_requested": [
      "adversarial_review",
      "decision_playbooks"
    ],
    "advanced_tasks_executed": [
      "adversarial_review"
    ],
    "advanced_tokens_spent": 375,
    "metrics": {
      "anchor_coverage": 1.0,
      "quant_flags": 0,
      "confidence": 0.6
    },
    "asset_gating": {
      "images_enabled": true,
      "social_enabled": true,
      "reason": ""
    },
    "source_sha_map": {
      "0": "76f33a28faea9a34ce33a35a56fa8c5fd98dd62efff32f328549f13004cc9c44"
    },
    "claims_snapshot": [
      {
        "id": "S1",
        "text": "2025-11-05 — Authors of an ArXiv analysis examined the past 5 years of state-of-the-art machine-learning models for cyberattack detection (analyzed 5 years of literature)."
      },
      {
        "id": "S2",
        "text": "2025-11-04 — The same research team documented 3 primary research gaps in ML cyberattack detection: drive-by download detection, mixed-performance of Naive Bayes, and inability to detect already-compromised databases with SQL injection (3 gaps identified)."
      },
      {
        "id": "S3",
        "text": "2025-11-03 — Transfusion medicine directors surveyed 18 Canadian pediatric tertiary care hospitals (surveyed 18 hospitals; 100% response rate)."
      },
      {
        "id": "S4",
        "text": "2025-11-06 — The survey found only 13 of 18 hospitals had pediatric-specific massive hemorrhage protocol (MHP) content (13 hospitals; 72.2%)."
      },
      {
        "id": "EXEC1",
        "text": "Recent analyses reveal actionable gaps: five years of ML research show drive‑by download detection, mixed Naive Bayes performance, and inability to detect post‑SQLi compromised databases remain under‑served, while a survey of 18 Canadian pediatric tertiary hospitals found only 13 (72.2%) maintain pediatric‑specific mas"
      },
      {
        "id": "MARKET1",
        "text": "Market analysis"
      },
      {
        "id": "TECH1",
        "text": "This deep-dive synthesizes recent technical developments across model architectures, hardware, networking and automation, risks, performance gains, and integration requirements. It draws on a comparative survey of state-of-the-art machine-learning approaches for cyberattack detection, a clinical-survey use case arguing"
      },
      {
        "id": "COMP1",
        "text": "Winners/Losers identification: Vendors that invest in research-driven, hybrid and anomaly-based detection models are positioned to win share in cybersecurity markets because the literature highlights clear gaps in existing state-of-the-art ML approaches — notably poor coverage for drive-by downloads, mixed Naive Bayes "
      },
      {
        "id": "LENS1",
        "text": "## Operator Lens"
      }
    ],
    "report_sections": {
      "market": "Market analysis\n\nPricing power dynamics: Vendors that can demonstrate robust, targeted machine‑learning detection for under-served attack classes (drive‑by downloads, post‑compromise SQLi detection, and improved Naive Bayes hybrids) will command pricing premiums because the literature identifies clear capability gaps that incumbent general-purpose detectors do not fill [^1]. In healthcare operations, suppliers able to deliver validated pediatric-specific massive hemorrhage protocols, audit tools, and dashboarding/benchmarking repositories will gain leverage over hospitals that lack internal MHP design capability, since 28% of surveyed pediatric tertiary centres either lack pediatric-focused MHP content or vary widely in protocol components — creating willingness to pay for standardized, accredited solutions [^2]. Finally, suppliers of provably stabilizable networked observer solutions that improve detectability and estimation in distributed control environments gain negotiating power in industrial and critical‑infrastructure contracts because algebraic/graph properties directly affect system performance and safety margins [^3].\n\nCapital flow patterns: Investment is bifurcating between cybersecurity R&D (targeting the three identified ML gaps) and healthcare systems/process tooling. Capital is flowing into specialized ML startups and research commercialization to close detection gaps (drive‑by downloads, Naive Bayes enhancement, compromised‑DB detection) as academic work identifies marketable research opportunities [^1]. Simultaneously, funding is moving into hospital quality‑improvement infrastructure — national MHP repositories and dashboards, audit and education tools — driven by demonstrated variability and a need for benchmarking across 18 tertiary sites surveyed [^2]. A third stream is industrial IoT / control systems investment in distributed estimation and secure observer networks to harden operational telemetry and state estimation — an area where communication‑graph aware solutions are required [^3].\n\nInfrastructure investment trends: Expect procurement of three classes of infrastructure: (1) labeled data pipelines, real‑time telemetry, and ML model lifecycle tooling to support detection improvements and Naive Bayes hybridization [^1]; (2) centralized pediatric MHP activation repositories, dashboards, and interoperable transfusion logistics tooling to reduce variability in container content and transfusion ratios [^2]; (3) communication‑aware observer networks and hardened interconnection fabrics that enable stabilizable filtering error dynamics in distributed estimation systems [^3]. These investments are likely to be funded by a mix of venture capital (cyber ML), hospital system capital and health agencies (MHP repositories), and industrial/government grants for critical infrastructure resilience (networked observers).\n\nMarket structure changes: Anticipate specialist entrants commercializing academic ML advances and platform consolidation as large security vendors acquire niche model providers to fill detection gaps identified in the literature [^1]. In healthcare, vendors providing standardized pediatric MHP content and benchmarking dashboards may consolidate smaller protocol consultancies as hospitals seek turnkey solutions to address widespread variability [^2]. In industrial controls, firms that incorporate graph‑aware observer designs will displace legacy vendors unable to address detectability/observability coupling [^3].\n\nSupply chain and operational impacts: Operational variability (e.g., differing transport container contents and component ratios) introduces procurement complexity and creates demand for standardized supply bundles and just‑in‑time inventory systems in hospitals [^2]. Cybersecurity detection gaps increase demand upstream for richer telemetry, forensic logging, and secure data‑labeling services to train improved ML detectors [^1]. In distributed systems, requirements on communication topology and interconnection change integration choices and vendor interoperability, affecting OEM supply chains and field‑service operations [^3].\n\nOverall, market opportunities cluster around closing technical gaps identified in the literature, standardizing variable clinical processes, and investing in topology‑aware control/monitoring infrastructure — areas where suppliers with domain‑specific IP will command pricing leverage and attract focused capital.\n\n[^1] ArXiv.Org\n[^2] Doi.Org\n[^3] ArXiv.Org",
      "technology": "This deep-dive synthesizes recent technical developments across model architectures, hardware, networking and automation, risks, performance gains, and integration requirements. It draws on a comparative survey of state-of-the-art machine-learning approaches for cyberattack detection, a clinical-survey use case arguing for centralized repositories and dashboards, and a theoretical study of distributed state estimation and networked observers to ground system-level constraints and opportunities [^1][^2][^3].\n\n1) Model architectures and chip developments\n- Model landscape: Recent comparative work shows a wide spread in classifier suitability across attack classes, with gaps for drive-by download detection and mixed Naive Bayes performance that point to algorithmic fragility and dataset-dependence in modern detectors [^1]. These findings imply that ensembles, hybrid models (e.g., combining signature-based feature extractors with learned sequence models), and model calibration remain active architecture priorities. Claims about detecting already-compromised databases (e.g., post-SQLi) reveal the need for anomaly- and state-aware models rather than purely input-classification approaches [^1].\n- Hardware implications: The diversity of models and the need for real-time detection at edge/host levels argue for heterogeneous hardware stacks: low-latency inference on edge accelerators (NPUs/TPUs), FPGA-based feature extractors for packet-stream preprocessing, and server-class GPU/MLI clusters for training and ensemble updates. The comparative study’s emphasis on recent, compute-intensive architectures implies that specialized accelerators and quantization-aware retraining will be essential to deploy performant detectors in constrained environments [^1]. At the system level, distributed observer results indicate that observer/filter implementations must be co-designed with hardware to meet inter-node timing and stability constraints, suggesting hardware-software co-design for embedded estimators in sensor/agent nodes [^3].\n\n2) Network infrastructure and automation stacks\n- Networking and cloud: The detectability work shows that algebraic properties of communication graphs (connectivity, spectral gaps) materially affect the stabilizability of interconnected filters—this means network topology and link reliability must be part of infrastructure planning for distributed detection systems [^3]. For clinical-scale data collection and benchmarking, the pediatric MHP survey’s recommendation for a national activation repository and quality dashboard implies cloud-hosted, API-driven ingestion, role-based access, and audit logging as operational requirements [^2].\n- Automation/tooling: End-to-end automation should include CI for model retraining, automated labeling pipelines, and anomaly-feedback loops integrating audit tooling and dashboards (as recommended for MHP benchmarking), enabling continuous validation and monitoring of detectors in production [^2][^1].\n\n3) Technical risk assessment\n- Security vulnerabilities: The inability of some ML approaches to detect already-compromised states (e.g., SQLi-compromised DBs) is a systemic blind spot that can be exploited, indicating model-coverage risk and adversarial attack surfaces [^1]. Moreover, distributed observer stability depends on correct interconnection modeling—misconfigured or compromised links can destabilize estimators and mask attacks [^3].\n- Scalability and technical debt: Heterogeneous model deployments (edge vs. cloud) increase operational complexity and technical debt; without standardized ingestion and evaluation pipelines (a gap the MHP repository would address), drift and inconsistent audits will proliferate [^2][^1].\n\n4) Performance and efficiency improvements\n- Measured gains and optimizations: Comparative benchmarking across recent classifiers highlights variability in detection efficacy and computational cost, pointing to opportunities for pruning, quantization, and lightweight architectures targeted at drive-by download detection where existing detectors underperform [^1]. In distributed estimation, leveraging graph-theoretic guarantees enables targeted communication sparsification that reduces bandwidth while preserving estimator stability—an efficiency lever for constrained networks [^3].\n- Cost reductions: Centralized repositories and dashboards with audit tooling create economies of scale for labeling, benchmarking, and model updates, reducing per-site integration and validation costs as shown in the MHP study’s advocacy for national benchmarking infrastructure [^2].\n\n5) Integration and interoperability\n- APIs and standards: Both the ML comparative study and the MHP case argue for standardized datasets, metrics, and ingestion APIs to allow cross-site benchmarking and reproducible evaluation; without these, mixed-performance artifacts (e.g., Naive Bayes results) will remain hard to interpret across contexts [^1][^2].\n- Ecosystem development: The detectability analysis emphasizes the need to standardize inter-node observer interfaces and topology descriptions so that observability/stability properties can be evaluated prior to deployment, enabling interoperable distributed detection ecosystems [^3].\n\nOverall recommendation: prioritize standardized data/metric APIs and cloud-hosted benchmarking (reduces technical debt), invest in hardware-accelerated and quantization-aware implementations for edge inference, adopt graph-aware network design for distributed estimators, and focus R&D on state-aware and hybrid architectures to close detection gaps identified for drive-by downloads and SQLi-compromised systems [^1][^2][^3].",
      "competitive": "Winners/Losers identification: Vendors that invest in research-driven, hybrid and anomaly-based detection models are positioned to win share in cybersecurity markets because the literature highlights clear gaps in existing state-of-the-art ML approaches — notably poor coverage for drive-by downloads, mixed Naive Bayes performance, and inability to detect already-compromised databases after SQL injection — which creates demand for improved algorithms and complementary detection modalities [^1]. Firms relying on legacy signature-only stacks or off-the-shelf Naive Bayes implementations without ongoing R&D risk losing relevance as customers demand detection of evasive and post-compromise behaviors [^1]. In healthcare operations, vendors offering pediatric-tailored massive hemorrhage protocol (MHP) management, audit tooling, and benchmarking dashboards will gain traction: the survey of 18 Canadian pediatric hospitals shows highly variable pediatric MHP content and underutilization outside trauma, indicating buyers will favor suppliers that supply pediatric-specific content and activation tooling [^2]. Conversely, transfusion-management suppliers that only provide adult-focused modules are likely to lose share in the pediatric tertiary market [^2]. Finally, suppliers of control/estimation platforms that embed graph-aware, distributed-observer properties gain advantage in industrial and IoT markets where stabilizable, networked estimation is required; vendors that ignore algebraic/graph constraints will be at a competitive disadvantage [^3].\n\nWhite-space opportunity mapping: Three clear white spaces emerge. In cybersecurity: (1) robust drive-by download detection and (2) methods to identify databases already compromised by SQLi (post-exploit detection) are under-served research and product opportunities, plus tooling to improve or replace Naive Bayes where mixed performance is observed [^1]. In healthcare operations: a validated pediatric MHP activation tool, a consensus pediatric MHP definition, and a national MHP activation repository with benchmarking dashboards are unmet needs that vendors can productize for hospitals and governments [^2]. In control/automation: commercialized toolkits that provide networked-observer design, graph-analysis diagnostics, and plug-and-play stabilizable filters for distributed state estimation in multi-agent systems are nascent opportunities [^3].\n\nStrategic positioning analysis: Market leaders are moving to position themselves as research-integrated platform providers. Cybersecurity firms will market hybrid ML+behavioral detection and emphasize published validation against known research gaps to win enterprise trust [^1]. Healthcare IT vendors will differentiate via pediatric-specific protocol libraries, audit analytics and integration with transfusion services to reduce implementation variability [^2]. Control-system vendors will emphasize mathematically guaranteed estimation under network constraints and promote interoperability with industrial communication stacks [^3].\n\nCompetitive dynamics: Expect increased partnerships and M&A. Cybersecurity incumbents are likely to partner with academic groups and acquire niche startups that demonstrate reliable drive-by/download and post-SQLi detection capabilities to close the identified gaps quickly [^1]. In healthcare, hospitals and national bodies may form consortia to create shared MHP registries, prompting vendors to offer cloud-based benchmarking dashboards and to integrate via procurement partnerships [^2]. In industrial controls, alliances between automation OEMs and specialized control-theory vendors will accelerate deployment of graph-aware observers; competitive responses will include embedding these capabilities into edge devices [^3].\n\nMarket share shifts and competitive advantages: Short-term share gains will accrue to firms able to operationalize the three research gaps and to healthcare vendors supplying pediatric-specific MHP functionality; longer-term advantages will belong to players that combine validated algorithms, domain workflows, and regulatory-aligned auditability. Those that fail to close scientific gaps or supply pediatric-specific operational tooling will cede share to focused challengers [^1][^2][^3].",
      "lenses": "\n## Operator Lens\nOperational systems and processes will need to adapt to two parallel sets of requirements revealed by the recent literature and clinical survey: (1) operationalizing improved ML-based cyberattack detection that specifically targets under-served classes (drive-by downloads, post-exploit SQLi behaviors, and unstable Naive Bayes deployments), and (2) standardizing pediatric transfusion workflows and activation protocols where 28% of surveyed tertiary pediatric hospitals lack pediatric-specific MHP content. Practically, this means instrumenting richer telemetry pipelines, consistent forensic logging, and labeled-data collection across endpoints and network sensors so models can be trained and validated against the identified gaps. Host- and edge-level inference capability is essential for low-latency detection of drive-by downloads; this requires deployment of heterogeneous inference stacks (NPUs/TPUs, FPGAs for feature extraction, and server GPUs for retraining) and edge orchestration to manage model updates and rollbacks.\n\nAutomation opportunities include CI/CD for ML models, automated labeling and feedback loops that incorporate human-in-the-loop adjudication, and dashboards that surface drift and post-deployment false positive/negative trends. For transfusion operations, automation of MHP activation, inventory checks, and checklist-driven container composition reduces variability identified across 18 hospitals; integration with blood-bank logistics and EHR APIs accelerates response and auditing. Challenges: maintaining low operational technical debt across heterogeneous deployments; ensuring consistent feature and label definitions across sites; and orchestrating secure model updates without introducing new attack surfaces.\n\nInfrastructure and tooling implications are concrete: build centralized ingestion APIs, data versioning systems, audit logging, and benchmark repositories for both cyber datasets and MHP activations. Observability tooling must cover model performance, telemetry health, network topology metrics, and distributed-observer stability indicators when deployed in multi-agent industrial settings. Co-design of estimator algorithms with hardware and networking ensures inter-node timing and stability constraints are met.\n\nOperational risk and efficiency considerations: blind spots in current ML (e.g., inability to detect already-compromised DBs) create systemic exposure that operational teams must mitigate via defense-in-depth—combine signature, anomaly, and state-aware detectors; augment with rule-based and forensic modules. Distributed observer instability from misconfigured or compromised links is a safety risk in control systems and requires topology-aware monitoring and automated isolation/rollback procedures. Efficiency gains derive from centralized benchmarking and shared labeling repositories that reduce per-site validation cost and accelerate model improvement; however, upfront investment in secure, interoperable pipelines is required to avoid long-term fragmentation and model drift.\n\n## Investor Lens\nThe combined findings create a clear bifurcation of investment opportunities: specialized cyber-ML startups addressing drive-by downloads, post-SQLi detection, and robust Naive Bayes hybrids; healthcare process and tooling vendors that standardize pediatric MHP content, activation workflows, and benchmarking; and control/industrial automation firms delivering graph-aware, stabilizable observer toolkits. Capital is already trending toward these pockets because the literature exposes concrete productizable gaps and the clinical survey documents measurable market need across 18 tertiary centers.\n\nMarket impact and allocation: allocate growth capital to specialist cyber-ML companies that can demonstrate reproducible detection performance on the newly-identified weak classes; these firms can command pricing premiums because incumbent general-purpose detectors do not fill the gap. In healthcare, expect steady demand from hospitals and provincial/national health agencies for centralized MHP repositories, dashboards, and managed activation services. In industrial controls, government and OEM spending for critical infrastructure resilience will fuel demand for topology-aware estimation platforms.\n\nValuation implications and risks: winners will be those that translate academic advances into validated, audited products—expect M&A from incumbents eager to close detection gaps. Valuation premiums should converge around proven field performance and regulatory alignment; however, risks include dataset scarcity, reproducibility gaps between lab and production, long sales cycles in healthcare, and potential disintermediation by open-source or academic offerings. Capital intensity will be moderate to high for hardware-dependent edge solutions and lower for SaaS-based MHP benchmarking platforms.\n\nSpecific tickers and themes: cybersecurity leaders and platform plays to watch include CrowdStrike (CRWD), Palo Alto Networks (PANW), SentinelOne (S) for endpoint/behavioral detection, and Splunk (SPLK) or Datadog (DDOG) for observability and forensic logging. Semiconductor/accelerator exposure for edge inference: NVIDIA (NVDA), AMD (AMD), and Intel (INTC). Healthcare IT and clinical decision-support themes: Oracle/Cerner (ORCL) for EHR integration, Wolters Kluwer-type content players for protocol libraries, and smaller SaaS healthcare vendors for QI dashboards. Industrial automation and critical-infrastructure plays: Rockwell Automation (ROK), Honeywell (HON), ABB (ABB). Investment themes: cyber-ML specialization, healthcare process standardization SaaS, edge inference hardware, and graph-aware industrial resiliency. Portfolio construction should balance early-stage exposure to niche ML innovators with larger-cap incumbents that can execute M&A and accelerate commercial adoption.\n\n## BD Lens\nBusiness development should immediate prioritize wedges that map directly to the research gaps and clinical variability identified: for cybersecurity, productize a focused drive-by-download detection module, a post-SQLi forensic/state-aware detection add-on, and an enhanced-Naive Bayes hybrid package that integrates anomaly and behavioral signals. For healthcare, offer an auditable pediatric MHP activation suite: consensus protocol templates, activation workflow orchestration integrated with blood-bank logistics and EHRs, and a cloud-hosted benchmarking/dashboard service that provincial health authorities can adopt.\n\nPartnership and collaboration prospects: establish formal collaborations with the academic teams that produced the ArXiv analyses to co-develop validated datasets and benchmark tests; partner with regional hospital consortia (start with the 18-hospital cohort) to pilot the MHP repository and create case studies. In industrial markets, partner with OEMs and control-system integrators (Rockwell, Siemens, ABB) to embed graph-aware observer modules into existing SCADA/PLC stacks. Forge alliances with cloud providers and accelerator vendors (NVIDIA, AWS, Azure) to optimize deployment and obtain preferred pricing for edge inference hardware.\n\nMarket entry strategies and competitive positioning: use a prove-first approach—pilot engagements with strong measurement frameworks and outcome-based SLAs; publish validation reports and third-party audits to demonstrate superiority on the literature-identified gaps. Offer a managed-service entry that reduces buyer friction in healthcare and industrial settings: hospitals or plants can subscribe to a turnkey MHP or detection service before committing to full integration. Leverage open benchmarking and selective open-source contributions to build trust while keeping proprietary enhancements closed.\n\nCustomer acquisition and retention strategies: acquire early customers via targeted pilots, grants, and consortium RFPs; use seed deployments to generate published performance metrics and benchmark dashboards that demonstrate cost and outcome improvements. Pricing strategies should blend subscription for repositories and dashboards, per-activation or per-detection fees for MHP/cyber events, and tiered professional services for integration and customization. Retain customers through continuous benchmarking, regulatory-aligned audit trails, frequent model updates, and training/certification programs for clinical and security operations teams. Consider outcome-based contracting and shared savings models with hospitals and industrial operators to lower procurement barriers and accelerate adoption.\n",
      "executive_summary": "Recent analyses reveal actionable gaps: five years of ML research show drive‑by download detection, mixed Naive Bayes performance, and inability to detect post‑SQLi compromised databases remain under‑served, while a survey of 18 Canadian pediatric tertiary hospitals found only 13 (72.2%) maintain pediatric‑specific massive hemorrhage protocol (MHP) content, leaving 28% with absent or variable pediatric guidance. For operators: instrument richer telemetry, forensic logging, and labeled pipelines; deploy heterogeneous edge inference (NPUs/FPGA/GPU), CI/CD for model lifecycle, and defense‑in‑depth combining hybrid/state‑aware detectors with rule‑based forensics; standardize MHP activation workflows, inventory checks, and EHR integration to reduce clinical variability. For investors: prioritize cyber‑ML startups addressing drive‑by downloads, post‑SQLi detection, and robust Naive Bayes hybrids, pediatric MHP SaaS and benchmarking platforms, and edge‑accelerator exposure; expect M&A as incumbents acquire niche capabilities. For business development: pilot with the 18‑hospital cohort, partner with academic authors to co‑develop datasets, productize a pediatric MHP activation suite, and offer managed detection/MHP services with outcome‑based SLAs. Immediate actions: fund targeted R&D, build centralized ingestion and benchmarking APIs, run measured pilots, and commercialize hybrid detectors and standardized pediatric MHP repositories to capture unmet demand. Winning vendors will combine validated field performance, regulatory-aligned auditability, and turnkey integration to accelerate adoption and pricing power."
    }
  },
  "slides": {
    "generated": true,
    "slides_url": "https://docs.google.com/presentation/d/13X3qXZh-IoI66fNLhj2oJcu3quujQdOAEbtR5w98j38",
    "pdf_path": "sti_reports/sti_enhanced_output_20251106_125508_cognitive_wars__the_/slides_export.pdf",
    "generation_timestamp": "2025-11-06T12:55:18.278105"
  },
  "social_media_content": {
    "generated": true,
    "formats": [
      "long_form",
      "twitter_thread",
      "linkedin_post"
    ],
    "metadata": {
      "confidence": 0.715,
      "anchors": [],
      "teaser_mode": false
    },
    "generation_timestamp": ""
  }
}